MoneyWorks4Me

Concord Biotech - Quaterly Results

06 Sep 2023 Evaluate
The company witnessed a 7.64% growth in the revenue at Rs. 1948.28 millions for the quarter ended June 2023 as compared to Rs. 1810.01 millions during the year-ago period.Profit saw a slight increase of 12.46%to Rs. 484.71  millions from Rs. 431.01 millions.The company reported a good operating profit of 788.07 millions compared to 724.61 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202306 202206 % Var
Sales 1948.28 1810.01 7.64 1948.28 1810.01 7.64 1948.28 1810.01 7.64
Other Income 66.54 78.31 -15.03 66.54 78.31 -15.03 66.54 78.31 -15.03
PBIDT 788.07 724.61 8.76 788.07 724.61 8.76 788.07 724.61 8.76
Interest 7.53 10.38 -27.46 7.53 10.38 -27.46 7.53 10.38 -27.46
PBDT 780.54 714.23 9.28 780.54 714.23 9.28 780.54 714.23 9.28
Depreciation 130.41 135.67 -3.88 130.41 135.67 -3.88 130.41 135.67 -3.88
PBT 650.13 578.56 12.37 650.13 578.56 12.37 650.13 578.56 12.37
TAX 165.42 147.55 12.11 165.42 147.55 12.11 165.42 147.55 12.11
Deferred Tax 2.42 4.25 -43.06 2.42 4.25 -43.06 2.42 4.25 -43.06
PAT 484.71 431.01 12.46 484.71 431.01 12.46 484.71 431.01 12.46
Equity 104.62 104.62 0.00 104.62 104.62 0.00 104.62 104.62 0.00
PBIDTM(%) 40.45 40.03 1.04 40.45 40.03 1.04 40.45 40.03 1.04
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..